1.Department of Ultrasound, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing 400037, China
2.Department of Chemical Defense Medicine, School of Military Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China
3.Institute of Toxicology, School of Military Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China
4.Institute of Pathology and Southwest Cancer Centre, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China
* chenmingliang1987@163.com;
liuzhengs@163.com
纸质出版:2022-06
Scan QR Code
Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy
He et al.: Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy in vitro and in vivo. Mil Med Res, 2022, 9: 9.
Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy
He et al.: Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy in vitro and in vivo. Mil Med Res, 2022, 9: 9. DOI: 10.1186/s40779-022-00369-0.
Background:
2
Ultrasound-triggered microbubble destruction (UTMD) is a widely used noninvasive technology in both military and civilian medicine
which could enhance radiosensitivity of various tumors. However
little information is available regarding the effects of UTMD on radiotherapy for glioblastoma or the underlying mechanism. This study aimed to delineate the effect of UTMD on the radiosensitivity of glioblastoma and the potential involvement of autophagy.
Methods:
2
GL261
U251 cells and orthotopic glioblastoma-bearing mice were treated with ionizing radiation (IR) or IR plus UTMD. Autophagy was observed by confocal microscopy and transmission electron microscopy. Western blotting and immunofluorescence analysis were used to detect progesterone receptor membrane component 1 (PGRMC1)
light chain 3 beta 2 (LC3B2) and sequestosome 1 (SQSTM1/p62) levels. Lentiviral vectors or siRNAs transfection
and fluorescent probes staining were used to explore the underlying mechanism.
Results:
2
UTMD enhanced the radiosensitivity of glioblastoma
in vitro
and
in vivo
(
P
<
0.01). UTMD inhibited autophagic flux by disrupting autophagosome-lysosome fusion without impairing lysosomal function or autophagosome synthesis in IR-treated glioblastoma cells. Suppression of autophagy by 3-methyladenine
bafilomycin A1 or ATG5 siRNA had no significant effect on UTMD-induced radiosensitization in glioblastoma cells (
P
<
0.05). Similar results were found when autophagy was induced by rapamycin or ATG5 overexpression (P
>
0.05). Furthermore
UTMD inhibited PGRMC1 expression and binding with LC3B2 in IR-exposed glioblastoma cells (
P
<
0.01). PGRMC1 inhibitor AG-205 or PGRMC1 siRNA pretreatment enhanced UTMD-induced LC3B2 and p62 accumulation in IR-exposed glioblastoma cells
thereby promoting UTMD-mediated radiosensitization (
P
<
0.05). Moreover
PGRMC1 overexpression abolished UTMD-caused blockade of autophagic degradation
subsequently inhibiting UTMD-induced radiosensitization of glioblastoma cells. Finally
compared with IR plus UTMD group
PGRMC1 overexpression significantly increased tumor size [(3.8±1.1) mm
2
vs
. (8.0±1.9) mm
2
P
<
0.05] and decreased survival time [(67.2±2.6) d
vs
. (40.0±1.2) d
P
=0.0026] in glioblastoma-bearing mice.
Conclusions:
2
UTMD enhanced the radiosensitivity of glioblastoma partially by disrupting PGRMC1-mediated autophagy.
Dewitt JC , Jordan JT , Frosch MP , Samore WR , Iafrate AJ , Louis DN , et al . Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations . Neuro Oncol . 2017 ; 19 ( 12 ): 1640 - 50 .
Agnihotri S , Burrell KE , Wolf A , Jalali S , Hawkins C , Rutka JT , et al . Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies . Arch Immunol Ther Exp (Warsz) . 2013 ; 61 ( 1 ): 25 - 41 .
Gallego O . Nonsurgical treatment of recurrent glioblastoma . Curr Oncol . 2015 ; 22 ( 4 ): e273 - 81 .
Wang LY , Zheng SS . Advances in low-frequency ultrasound combined with microbubbles in targeted tumor therapy . J Zhejiang Univ Sci B . 2019 ; 20 ( 4 ): 291 - 9 .
Mikolajczyk A , Khosrawipour T , Kulas J , Migdal P , Arafkas M , Nicpon J , et al . The structural effect of high intensity ultrasound on peritoneal tissue: a potential vehicle for targeting peritoneal metastases . BMC Cancer . 2020 ; 20 ( 1 ): 481 .
Lau H , Khosrawipour T , Mikolajczyk A , Frelkiewicz P , Nicpon J , Arafkas M , et al . Intraperitoneal chemotherapy of the peritoneal surface using high-intensity ultrasound (HIUS): investigation of technical feasibility, safety and possible limitations . J Cancer . 2020 ; 11 ( 24 ): 7209 - 15 .
El Kaffas A , Czarnota GJ . Biomechanical effects of microbubbles: from radiosensitization to cell death . Future Oncol . 2015 ; 11 ( 7 ): 1093 - 108 .
Burke CW , Price RJ . Contrast ultrasound targeted treatment of gliomas in mice via drug-bearing nanoparticle delivery and microvascular ablation . J Vis Exp . 2010 ; 46 : 2145 .
Mikolajczyk A , Khosrawipour T , Martino A , Kulas J , Pieczka M , Zacharski M , et al . Enabling microparticle imprinting to achieve penetration and local endurance in the peritoneum via high-intensity ultrasound (HIUS) for the treatment of peritoneal metastasis . Int J Surg Oncol . 2020 ; 2020 : 9679385 .
Zhao YZ , Lin Q , Wong HL , Shen XT , Yang W , Xu HL , et al . Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery . J Control Release . 2016 ; 224 : 112 - 25 .
Mikolajczyk A , Khosrawipour V , Kulas J , Kocielek K , Migdal P , Arafkas M , et al . Release of doxorubicin from its liposomal coating via high intensity ultrasound . Mol Clin Oncol . 2019 ; 11 ( 5 ): 483 - 7 .
Ulasov I , Fares J , Timashev P , Lesniak MS . Editing cytoprotective autophagy in glioma: an unfulfilled potential for therapy . Trends Mol Med . 2020 ; 26 ( 3 ): 252 - 62 .
Galavotti S , Bartesaghi S , Faccenda D , Shaked-Rabi M , Sanzone S , Mcevoy A , et al . The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells . Oncogene . 2013 ; 32 ( 6 ): 699 - 712 .
Dolma S , Selvadurai HJ , Lan X , Lee L , Kushida M , Voisin V , et al . Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells . Cancer Cell . 2016 ; 29 ( 6 ): 859 - 73 .
Huang T , Kim CK , Alvarez AA , Pangeni RP , Wan X , Song X , et al . MST4 phosphorylation of ATG4B regulates autophagic activity, tumorigenicity, and radioresistance in glioblastoma . Cancer Cell . 2017 ; 32 ( 6 ): 840-55.e8 .
Huang T , Wan X , Alvarez AA , James CD , Song X , Yang Y , et al . MIR93 (microRNA-93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy . Autophagy . 2019 ; 15 ( 6 ): 1100 - 11 .
Wang X , Lin Q , Zhang T , Wang X , Cheng K , Gao M , et al . Low-intensity pulsed ultrasound promotes chondrogenesis of mesenchymal stem cells via regulation of autophagy . Stem Cell Res Ther . 2019 ; 10 ( 1 ): 41 .
Wang P , Leung AW , Xu C . Low-intensity ultrasound-induced cellular destruction and autophagy of nasopharyngeal carcinoma cells . Exp Ther Med . 2011 ; 2 ( 5 ): 849 - 52 .
Wu Y , Liu X , Qin Z , Hu L , Wang X . Low-frequency ultrasound enhances chemotherapy sensitivity and induces autophagy in PTX-resistant PC-3 cells via the endoplasmic reticulum stress-mediated PI3K/Akt/mTOR signaling pathway . Onco Targets Ther . 2018 ; 11 : 5621 - 30 .
Wang YU , Chen YN , Zhang W , Yang YU , Shen E , Hu B . Upregulation of Beclin-1 expression in DU-145 cells following low-frequency ultrasound irradiation combined with microbubbles . Oncol Lett . 2015 ; 10 ( 4 ): 2487 - 90 .
Ruan X , Cai G , Wei Y , Gu M , Zhang Y , Zhao Y , et al . Association of circulating progesterone receptor membrane component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers . Menopause . 2020 ; 27 ( 2 ): 183 - 93 .
Hlavaty J , Ertl R , Miller I , Gabriel C . Expression of progesterone receptor membrane component 1 (PGRMC1), progestin and AdipoQ receptor 7 (PAQPR7), and plasminogen activator inhibitor 1 RNA-binding protein (PAIRBP1) in glioma spheroids in vitro . Biomed Res Int . 2016 ; 2016 : 8065830 .
Zhao Y , Ruan X . Identification of PGRMC1 as a candidate oncogene for head and neck cancers and its involvement in metabolic activities . Front Bioeng Biotechnol . 2020 ; 7 : 438 .
Wheeler KT , Wang LM , Wallen CA , Childers SR , Cline JM , Keng PC , et al . Sigma-2 receptors as a biomarker of proliferation in solid tumours . Br J Cancer . 2000 ; 82 ( 6 ): 1223 - 32 .
Kabe Y , Nakane T , Koike I , Yamamoto T , Sugiura Y , Harada E , et al . Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance . Nat Commun . 2016 ; 7 : 11030 .
Mir SUR , Schwarze SR , Jin L , Zhang J , Friend W , Miriyala S , et al . Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy . Autophagy . 2013 ; 9 ( 10 ): 1566 - 78 .
Zhu X , Ji M , Han Y , Guo Y , Zhu W , Gao F , et al . PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment . Int J Oncol . 2017 ; 50 ( 3 ): 835 - 46 .
Leinenga G , Langton C , Nisbet R , Götz J . Ultrasound treatment of neurological diseases-current and emerging applications . Nat Rev Neurol . 2016 ; 12 ( 3 ): 161 - 74 .
Liu P , Wang X , Zhou S , Hua X , Liu Z , Gao Y . Effects of a novel ultrasound contrast agent with long persistence on right ventricular pressure: comparison with SonoVue . Ultrasonics . 2011 ; 51 ( 2 ): 210 - 4 .
Peng C , Wu Y , Yang Y , Li N , Chen X , Gu L , et al . Using ultrasound-targeted microbubble destruction to enhance radiotherapy of glioblastoma . J Cancer Res Clin Oncol . 2021 ; 147 ( 5 ): 1355 - 63 .
Chen M , Dong X , Deng H , Ye F , Zhao Y , Cheng J , et al . Targeting TRPV1- mediated autophagy attenuates nitrogen mustard-induced dermal toxicity . Signal Transduct Target Ther . 2021 ; 6 ( 1 ): 29 .
Kwak BK , Geschwind JFH , Rao PP , Ota S , Loffroy R , Lin M , et al . High-resolution ultrasound in research of mouse orthotopic glioma and ultrasound-guided cell implant . AMI . 2011 ; 1 ( 2 ): 24 - 32 .
Oh DS , Adamson DC , Kirkpatrick JP . Targeted radiotherapy for malignant gliomas . Curr Drug Discov Technol . 2012 ; 9 ( 4 ): 268 - 79 .
Hardee ME , Marciscano AE , Medina-Ramirez CM , Zagzag D , Narayana A , Lonning SM , et al . Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-beta . Cancer Res . 2012 ; 72 ( 16 ): 4119 - 29 .
Lai P , Tarapacki C , Tran WT , El Kaffas A , Lee J , Hupple C , et al . Breast tumor response to ultrasound mediated excitation of microbubbles and radiation therapy in vivo . Oncoscience . 2016 ; 3 ( 3–4 ): 98 - 108 .
Kim HC , Al-Mahrouki A , Gorjizadeh A , Sadeghi-Naini A , Karshafian R , Czarnota GJ . Quantitative ultrasound characterization of tumor cell death: ultrasound-stimulated microbubbles for radiation enhancement . PLoS One . 2014 ; 9 ( 7 ): e012343 .
Al-Mahrouki AA , Wong E , Czarnota GJ . Ultrasound-stimulated microbubble enhancement of radiation treatments: endothelial cell function and mechanism . Oncoscience . 2015 ; 2 ( 12 ): 944 - 57 .
Amaravadi RK , Kimmelman AC , Debnath J . Targeting autophagy in cancer: recent advances and future directions . Cancer Discov . 2019 ; 9 ( 9 ): 1167 - 81 .
Gao L , Zheng H , Cai Q , Wei L . Autophagy and tumour radiotherapy . Adv Exp Med Biol . 2020 ; 1207 : 375 - 87 .
Zhuang W , Qin Z , Liang Z . The role of autophagy in sensitizing malignant glioma cells to radiation therapy . Acta Biochim Biophys Sin (Shanghai) . 2009 ; 41 ( 5 ): 341 - 51 .
Ye H , Chen M , Cao F , Huang H , Zhan R , Zheng X . Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosis . BMC Neurol . 2016 ; 16 ( 1 ): 178 .
Hou W , Song L , Zhao Y , Liu Q , Zhang S . Inhibition of Beclin-1-mediated autophagy by microRNA-17-5p enhanced the radiosensitivity of glioma cells . Oncol Res . 2017 ; 25 ( 1 ): 43 - 53 .
Zheng W , Chen Q , Wang C , Yao D , Zhu L , Pan Y , et al . Inhibition of cathepsin D (CTSD) enhances radiosensitivity of glioblastoma cells by attenuating autophagy . Mol Carcinog . 2020 ; 59 ( 6 ): 651 - 60 .
Pandit R , Leinenga G , Götz J . Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions . Theranostics . 2019 ; 9 ( 13 ): 3754 - 67 .
Hughes AL , Powell DW , Bard M , Eckstein J , Barbuch R , Link AJ , et al . Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes . Cell Metab . 2007 ; 5 ( 2 ): 143 - 9 .
Ryu CS , Klein K , Zanger UM . Membrane associated progesterone receptors: promiscuous proteins with pleiotropic functions - focus on interactions with cytochromes P450 . Front Pharmacol . 2017 ; 8 : 159 .
Ahmed IS , Rohe HJ , Twist KE , Craven RJ . Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity . J Biol Chem . 2010 ; 285 ( 32 ): 24775 - 82 .
Ibsen S , Tong A , Schutt C , Esener S , Chalasani SH . Sonogenetics is a noninvasive approach to activating neurons in Caenorhabditis elegans . Nat Commun . 2015 ; 6 : 8264 .
0
浏览量
0
Downloads
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621